G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 95 filers reported holding G1 THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.97 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $90,000 | -39.6% | 11,849 | -19.1% | 0.00% | – |
| Q4 2021 | $149,000 | -21.2% | 14,647 | +4.1% | 0.00% | -100.0% |
| Q3 2021 | $189,000 | -51.4% | 14,070 | -20.6% | 0.00% | 0.0% |
| Q2 2021 | $389,000 | +8.4% | 17,730 | +18.9% | 0.00% | 0.0% |
| Q1 2021 | $359,000 | +48.3% | 14,910 | +11.1% | 0.00% | 0.0% |
| Q4 2020 | $242,000 | +103.4% | 13,425 | +30.2% | 0.00% | 0.0% |
| Q3 2020 | $119,000 | -54.1% | 10,309 | -3.4% | 0.00% | 0.0% |
| Q2 2020 | $259,000 | -22.9% | 10,668 | -16.1% | 0.00% | -50.0% |
| Q4 2019 | $336,000 | +5.3% | 12,714 | -9.3% | 0.00% | 0.0% |
| Q3 2019 | $319,000 | -22.4% | 14,011 | +4.6% | 0.00% | 0.0% |
| Q2 2019 | $411,000 | +62.5% | 13,391 | -12.1% | 0.00% | 0.0% |
| Q1 2019 | $253,000 | -11.8% | 15,231 | +1.5% | 0.00% | 0.0% |
| Q4 2018 | $287,000 | -66.1% | 15,003 | -7.2% | 0.00% | -66.7% |
| Q3 2018 | $846,000 | +18.5% | 16,171 | -1.6% | 0.01% | +20.0% |
| Q2 2018 | $714,000 | +29.6% | 16,431 | +10.4% | 0.01% | +25.0% |
| Q1 2018 | $551,000 | +69.0% | 14,877 | -9.5% | 0.00% | +100.0% |
| Q4 2017 | $326,000 | – | 16,438 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 719,985 | $31,291,000 | 2.32% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 72,000 | $3,121,000 | 1.20% |
| EMERALD ADVISERS, LLC | 506,424 | $22,009,000 | 0.83% |
| Virtus ETF Advisers LLC | 18,103 | $787,000 | 0.70% |
| Birchview Capital, LP | 22,000 | $956,000 | 0.65% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 352,053 | $15,300,000 | 0.55% |
| Hillhouse Capital Management | 699,431 | $30,397,000 | 0.52% |
| Rock Springs Capital Management LP | 300,000 | $13,038,000 | 0.50% |
| BB BIOTECH AG | 352,607 | $15,324,000 | 0.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 287,000 | $12,473,000 | 0.44% |